Sie suchten nach: ipergliċemja (Maltesisch - Englisch)

ipergliċemja
hyperglycaemia

dijabete mellitus u ipergliċemja:
diabetes mellitus and hyperglycaemia:

diżidratazzjoni, ipokalimja, ipergliċemja iperkalemija, kakeksja, iperkalċimja, ipokalċimja, ipernatremija, iponatremija,
common: dehydration, hypokalaemia, hyperglycaemia.

ipertrigliċerimja, iperkolesterolemja, reżistenza għall- insulina, ipergliċemja u iperlactemja (ara sezzjoni 4. 4).
hypertriglyceridaemia, hypercholesterolaemia, insulin resistance, hyperglycaemia and hyperlactataemia (see section 4.4).

ipofosfatemja, akkumulazzjoni tal- fluwidu, ipoalbuminemja, polidipsja, ipergliċemja, ipokalċimja, ipogliċemja, iponatremja komuni:
radiation recall phenomenon

waqt provi kliniċi, ġew rappurati ipogliċemja u ipergliċemja b’ mod komuni u mhux komuni f' pazjenti dijabetiċi li kienu qed jirċievu ipogliċemiċi orali.
during clinical trials, hypoglycemia and hyperglycemia were uncommonly and commonly reported in diabetic patients receiving oral hypoglycemics.

l-effetti l-aktar komuni bi trisenox (li dehru f’1 minn 10 pazjenti) huma l-ipergliċemja (livelli għoljin ta’ glukożju fid-demm), ipomagneżjemija (livelli baxxi ta’ manjeżju fid-demm), ipokalemija (livelli baxxi ta’ potassju fid-demm), paresteżija (sensazzjonijiet anormali bħat-tnemnim), sturdament, uġigħ ta’ ras, takikardja (taħbit il-qalb mgħaġġel), dispnea (diffikultà fit-teħid tan-nifs), sindromu ta' differenzjazzjoni (kumplikazzjoni li tista' tkun fatali tal-kimoterapija f'pazjenti bl-apl), dijarrea, remettar, nawżja (dardir), ħakk, raxx, milaġija (uġigħ fil-ġogi), piressija (deni), uġigħ, għejja, edema (nefħa), interval qt imtawwal f’elektrokardjogramm (altrazzjoni tal-attività elettrika tal-qalb), u aktar livelli ta’ alanina aminotransferase u aspartate aminotransferase (enżimi tal-fwied).
the most common side effects with trisenox (seen in 1 patient in 10) are hyperglycaemia (high blood glucose levels), hypomagnesaemia (low blood magnesium levels), hypokalaemia (low blood potassium levels), paraesthesia (unusual sensations like pins and needles), dizziness, headache, tachycardia (rapid heartbeat), dyspnoea (difficulty breathing), differentiation syndrome (a potentially fatal complication of chemotherapy in patients with apl), diarrhoea, vomiting, nausea (feeling sick), pruritus (itching), rash, myalgia (muscle pain), pyrexia (fever), pain, fatigue (tiredness), oedema (swelling), prolonged qt interval on an electrocardiogram (an alteration of the electrical activity of the heart), and increased levels of alanine aminotransferase and aspartate aminotransferase (liver enzymes).